BioCentury
ARTICLE | Clinical News

Caldolor: Phase III data

July 26, 2010 7:00 AM UTC

In a double-blind Phase III trial in 60 patients with acute uncomplicated Plasmodium falciparum malaria being treated with oral artesunate plus mefloquine, 400 mg IV Caldolor every 6 hours for 72 hour...